Standard InChI: InChI=1S/C29H30N2O11/c1-3-13-14-7-12(40-11-20-22(32)23(33)24(34)25(42-20)27(36)37)5-6-18(14)30-21-15(13)9-31-19(21)8-17-16(26(31)35)10-41-28(38)29(17,39)4-2/h5-8,20,22-25,32-34,39H,3-4,9-11H2,1-2H3,(H,36,37)/t20-,22-,23+,24-,25-,29-/m0/s1
1.International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L.. (2010) Membrane transporters in drug development., 9 (3):[PMID:20190787][10.1038/nrd3028]
2.Arimori K, Kuroki N, Hidaka M, Iwakiri T, Yamsaki K, Okumura M, Ono H, Takamura N, Kikuchi M, Nakano M.. (2003) Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats., 20 (1):[PMID:12817897][10.1023/a:1023847521767]
3.Nozawa T, Minami H, Sugiura S, Tsuji A, Tamai I.. (2005) Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms., 33 (1):[PMID:15608127][10.1124/dmd.104.001909]
4.Nakatomi K, Yoshikawa M, Oka M, Ikegami Y, Hayasaka S, Sano K, Shiozawa K, Kawabata S, Soda H, Ishikawa T, Tanabe S, Kohno S.. (2001) Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells., 288 (1):[PMID:11688982][10.1006/bbrc.2001.5850]
5.Chu XY, Kato Y, Niinuma K, Sudo KI, Hakusui H, Sugiyama Y.. (1997) Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats., 281 (1):[PMID:9103511]
6.Jedlitschky, G G and 5 more authors. 1997-10-01 ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. [PMID:9355767]